🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety profile of single intravenous (IV) dose levels of pe...
Status
Terminated
Location
Research Facility
Start Date
2005-03
Trial ID
NCT00109291
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacodynamics (PD),...
Status
Completed
Location
Research Facility
Start Date
2005-07
Trial ID
NCT00228449
Treatments Being Tested
The purpose of the study is to determine the long-term safety in treatment-...
Status
Completed
Location
North America Research Institute
Start Date
2012-07-16
Trial ID
NCT01628107
Treatments Being Tested
This is a phase III, randomized, open-label, active-controlled study to eva...
Status
Recruiting
Location
Fudan Univeristy Zhongshan Hospital
Start Date
2025-10-31
Trial ID
NCT07494409
Treatments Being Tested
This study assessed the long-term efficacy, safety, and tolerability of int...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00090753
Treatments Being Tested
To determine the long term safety in treatment-emergent adverse events (TEA...
Status
Completed
Location
Azusa Dialysis Center
Start Date
2012-05-31
Trial ID
NCT01628120
Treatments Being Tested
The purpose of this study was to determine the dose ranges of peginesatide ...
Status
Completed
Location
Research Facility
Start Date
2006-12
Trial ID
NCT00434330
Treatments Being Tested
Since the onset of COVID-19, recommendations suggest the use of neuraxial a...
Status
Completed
Location
Aygün Güler
Start Date
2020-01-24
Trial ID
NCT05085652
Treatments Being Tested
The study will assess the immunogenicity, safety, and efficacy of HX575 epo...
Status
Completed
Location
Sandoz Investigative Site
Start Date
2012-04
Trial ID
NCT01576341
Treatments Being Tested
This study is a multi-institution, open-label, Phase 1b/2 clinical trial ev...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2021-03-30
Trial ID
NCT04798339
Treatments Being Tested